Osaic Holdings’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $436K | Sell |
51,495
-33,047
| -39% | -$315K | ﹤0.01% | 3482 |
|
|
2025
Q4 | $1.03M | Buy |
84,542
+58,952
| +230% | +$716K | ﹤0.01% | 2671 |
|
|
2025
Q3 | $316K | Sell |
25,590
-41,940
| -62% | -$502K | ﹤0.01% | 3816 |
|
|
2025
Q2 | $627K | Buy |
67,530
+67,180
| +19,194% | +$526K | ﹤0.01% | 2927 |
|
|
2025
Q1 | $2.56K | Sell |
350
-67,596
| -99% | -$520K | ﹤0.01% | 6495 |
|
|
2024
Q4 | $580K | Buy |
67,946
+253
| +0.4% | +$2.47K | ﹤0.01% | 2655 |
|
|
2024
Q3 | $589K | Buy |
67,693
+42
| +0.1% | +$346 | ﹤0.01% | 2710 |
|
|
2024
Q2 | $463K | Buy |
67,651
+66,526
| +5,913% | +$411K | ﹤0.01% | 2837 |
|
|
2024
Q1 | $10.2K | Hold |
1,125
| – | – | ﹤0.01% | 5729 |
|
|
2023
Q4 | $5.02K | Sell |
1,125
-350
| -24% | -$1.03K | ﹤0.01% | 6174 |
|
|
2023
Q3 | $4.63K | Sell |
1,475
-2,537
| -63% | -$10.4K | ﹤0.01% | 6307 |
|
|
2023
Q2 | $20.7K | Sell |
4,012
-945
| -19% | -$5.62K | ﹤0.01% | 5538 |
|
|
2023
Q1 | $26.1K | Buy |
4,957
+232
| +5% | +$1.1K | ﹤0.01% | 5405 |
|
|
2022
Q4 | $14K | Sell |
4,725
-100
| -2% | -$331 | ﹤0.01% | 5770 |
|
|
2022
Q3 | $20K | Buy |
4,825
+1,100
| +30% | +$5.54K | ﹤0.01% | 5585 |
|
|
2022
Q2 | $15K | Hold |
3,725
| – | – | ﹤0.01% | 5815 |
|
|
2022
Q1 | $18K | Sell |
3,725
-11,351
| -75% | -$62.9K | ﹤0.01% | 5770 |
|
|
2021
Q4 | $105K | Buy |
15,076
+10,500
| +229% | +$81.5K | ﹤0.01% | 4560 |
|
|
2021
Q3 | $46K | Buy |
4,576
+1,200
| +36% | +$13.5K | ﹤0.01% | 5179 |
|
|
2021
Q2 | $48K | Buy |
3,376
+875
| +35% | +$13.3K | ﹤0.01% | 5068 |
|
|
2021
Q1 | $41K | Buy |
2,501
+1,900
| +316% | +$36.6K | ﹤0.01% | 5006 |
|
|
2020
Q4 | $12K | Sell |
601
-549
| -48% | -$8.15K | ﹤0.01% | 5437 |
|
|
2020
Q3 | $9K | Buy |
1,150
+250
| +28% | +$2.08K | ﹤0.01% | 5334 |
|
|
2020
Q2 | $7K | Buy |
+900
| New | +$5.96K | ﹤0.01% | 5331 |
|
Other funds holding OCUL
DTC
ACA
SR
VA
VCM
